The Role of Macrophages in Sarcoma Tumor Microenvironment and Treatment

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2023 Nov 14

PMID 37958467

Authors

Agnieszka E Zajac

Anna M Czarnecka

Piotr Rutkowski

Affiliations

Soon will be listed here.

Abstract

Sarcomas are a heterogeneous group of malignant mesenchymal tumors, including soft tissue and bone sarcomas. Macrophages in the tumor microenvironment, involved in immunosuppression and leading to tumor development, are called tumor-associated macrophages (TAMs). TAMs are very important in modulating the microenvironment of sarcomas by expressing specific markers and secreting factors that influence immune and tumor cells. They are involved in many signaling pathways, such as p-STAT3/p-Erk1/2, PI3K/Akt, JAK/MAPK, and JAK/STAT3. TAMs also significantly impact the clinical outcomes of patients suffering from sarcomas and are mainly related to poor overall survival rates among bone and soft tissue sarcomas, for example, chondrosarcoma, osteosarcoma, liposarcoma, synovial sarcoma, and undifferentiated pleomorphic sarcoma. This review summarizes the current knowledge on TAMs in sarcomas, focusing on specific markers on sarcoma cells, cell-cell interactions, and the possibly involved molecular pathways. Furthermore, we discuss the clinical significance of macrophages in sarcomas as a potential target for new therapies, presenting clinical relevance, possible new treatment options, and ongoing clinical trials using TAMs in sarcoma treatment.

Citing Articles

Chordoma Spontaneous Regression After COVID-19.

Silva Junior L, Silva G, Garcia Campos M, Teixeira Junior A, Santos R, Santos O Viruses. 2025; 17(1).

PMID: 39861800 PMC: 11769020. DOI: 10.3390/v17010010.

Development and experimental verification of novel angiogenesis related prognostic model and immune infiltration characterization in osteosarcoma.

Ren S, Pan R, Wang Z Discov Oncol. 2024; 15(1):411.

PMID: 39237807 PMC: 11377409. DOI: 10.1007/s12672-024-01292-7.

Comprehensive bioinformatics analysis and cell line experiments revealed the important role of CDCA3 in sarcoma.

Li Y, Wu Z, Ding T, Zhang W, Guo H, Huang F Heliyon. 2024; 10(13):e32785.

PMID: 39035484 PMC: 11259814. DOI: 10.1016/j.heliyon.2024.e32785.

Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma.

Ingangi V, De Chiara A, Ferrara G, Gallo M, Catapano A, Fazioli F Cells. 2024; 13(11.

PMID: 38891109 PMC: 11171855. DOI: 10.3390/cells13110977.

Characterization of the malignant cells and microenvironment of infantile fibrosarcoma via single-cell RNA sequencing.

Li Y, Zhang Q, Yang R, Zhan Y, Li Z, Dai S Transl Pediatr. 2024; 13(4):596-609.

PMID: 38715675 PMC: 11071021. DOI: 10.21037/tp-24-66.

References

Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N . IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol. 2011; 12(3):231-8. DOI: 10.1038/ni.1990. View

Fan J, Qin X, He R, Ma J, Wei Q . Gene expression profiles for an immunoscore model in bone and soft tissue sarcoma. Aging (Albany NY). 2021; 13(10):13708-13725. PMC: 8202872. DOI: 10.18632/aging.202956. View

Koo J, Hayashi M, Verneris M, Lee-Sherick A . Targeting Tumor-Associated Macrophages in the Pediatric Sarcoma Tumor Microenvironment. Front Oncol. 2020; 10:581107. PMC: 7769312. DOI: 10.3389/fonc.2020.581107. View

Komohara Y, Takeya H, Wakigami N, Kusada N, Bekki H, Ishihara S . Positive correlation between the density of macrophages and T-cells in undifferentiated sarcoma. Med Mol Morphol. 2018; 52(1):44-51. DOI: 10.1007/s00795-018-0201-3. View

van Dalen F, van Stevendaal M, Fennemann F, Verdoes M, Ilina O . Molecular Repolarisation of Tumour-Associated Macrophages. Molecules. 2018; 24(1). PMC: 6337345. DOI: 10.3390/molecules24010009. View

Tsai R, Discher D . Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J Cell Biol. 2008; 180(5):989-1003. PMC: 2265407. DOI: 10.1083/jcb.200708043. View

Nystrom H, Jonsson M, Nilbert M, Carneiro A . Immune-cell infiltration in high-grade soft tissue sarcomas; prognostic implications of tumor-associated macrophages and B-cells. Acta Oncol. 2023; 62(1):33-39. DOI: 10.1080/0284186X.2023.2172688. View

Dumars C, Ngyuen J, Gaultier A, Lanel R, Corradini N, Gouin F . Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma. Oncotarget. 2016; 7(48):78343-78354. PMC: 5346643. DOI: 10.18632/oncotarget.13055. View

Chen Y, Song Y, Du W, Gong L, Chang H, Zou Z . Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci. 2019; 26(1):78. PMC: 6800990. DOI: 10.1186/s12929-019-0568-z. View

10.

Roszer T . Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms. Mediators Inflamm. 2015; 2015:816460. PMC: 4452191. DOI: 10.1155/2015/816460. View

11.

Germano G, Frapolli R, Simone M, Tavecchio M, Erba E, Pesce S . Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells. Cancer Res. 2010; 70(6):2235-44. DOI: 10.1158/0008-5472.CAN-09-2335. View

12.

Oike N, Kawashima H, Ogose A, Hotta T, Hatano H, Ariizumi T . Prognostic impact of the tumor immune microenvironment in synovial sarcoma. Cancer Sci. 2018; 109(10):3043-3054. PMC: 6172059. DOI: 10.1111/cas.13769. View

13.

Liguori M, Buracchi C, Pasqualini F, Bergomas F, Pesce S, Sironi M . Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment. Oncotarget. 2016; 7(27):41662-41676. PMC: 5173086. DOI: 10.18632/oncotarget.9340. View

14.

Sica A, Schioppa T, Mantovani A, Allavena P . Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer. 2006; 42(6):717-27. DOI: 10.1016/j.ejca.2006.01.003. View

15.

Gordon S, Maute R, Dulken B, Hutter G, George B, McCracken M . PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017; 545(7655):495-499. PMC: 5931375. DOI: 10.1038/nature22396. View

16.

Burns J, Wilding C, Krasny L, Zhu X, Chadha M, Tam Y . The proteomic landscape of soft tissue sarcomas. Nat Commun. 2023; 14(1):3834. PMC: 10310735. DOI: 10.1038/s41467-023-39486-2. View

17.

Aras S, Zaidi M . TAMeless traitors: macrophages in cancer progression and metastasis. Br J Cancer. 2017; 117(11):1583-1591. PMC: 5729447. DOI: 10.1038/bjc.2017.356. View

18.

Barclay A . Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function. Curr Opin Immunol. 2009; 21(1):47-52. PMC: 3128989. DOI: 10.1016/j.coi.2009.01.008. View

19.

Inagaki Y, Hookway E, Williams K, Hassan A, Oppermann U, Tanaka Y . Dendritic and mast cell involvement in the inflammatory response to primary malignant bone tumours. Clin Sarcoma Res. 2016; 6:13. PMC: 4968446. DOI: 10.1186/s13569-016-0053-3. View

20.

Nabeshima A, Matsumoto Y, Fukushi J, Iura K, Matsunobu T, Endo M . Tumour-associated macrophages correlate with poor prognosis in myxoid liposarcoma and promote cell motility and invasion via the HB-EGF-EGFR-PI3K/Akt pathways. Br J Cancer. 2015; 112(3):547-55. PMC: 4453656. DOI: 10.1038/bjc.2014.637. View